Medication for Binge Eating

作者: Susan L. McElroy , Anna I. Guerdjikova , Nicole Mori , Francisco Romo-Nava

DOI: 10.1007/978-3-030-43562-2_16

关键词: Binge eatingMedicineEating disordersWeight lossOpioidLisdexamfetamineFluoxetineBulimia nervosaPsychiatryTopiramate

摘要: This chapter reviews the use of medications in treatment individuals with bulimia nervosa (BN) and binge-eating disorder (BED), two mental disorders defined by presence binge eating. Drug classes evaluated include antidepressants, stimulants, other for attention-deficit/hyperactivity (ADHD), antiepileptic drugs, opioid antagonists, weight loss agents, among others. The only drugs regulatory approval eating are fluoxetine BN lisdexamfetamine BED. Other available established efficacy BED antidepressants (especially selective serotonin reuptake inhibitors) topiramate, though these compounds is modest at best. We found no evidence a drug developed specifically or Importantly, until eating, conditions that centrally acting associated beneficial psychotropic effects reduced appetite might be considered repurposing

参考文章(120)
Lucy F. Faulconbridge, Matthew R. Hayes, Regulation of Energy Balance and Body Weight by the Brain: A Distributed System Prone to Disruption Psychiatric Clinics of North America. ,vol. 34, pp. 733- 745 ,(2011) , 10.1016/J.PSC.2011.08.008
Susan L. McElroy, Anna I. Guerdjikova, Dennis D. Kim, Colleen Burns, Raúl Harris-Collazo, Ronald Landbloom, Eduardo Dunayevich, Naltrexone/Bupropion Combination Therapy in Overweight or Obese Patients With Major Depressive Disorder: Results of a Pilot Study The Primary Care Companion To The Journal of Clinical Psychiatry. ,vol. 15, pp. 0- 0 ,(2013) , 10.4088/PCC.12M01494
Alain Golay, Anne Laurent-Jaccard, Frank Habicht, Jean-Pierre Gachoud, Mireille Chabloz, Anne Kammer, Yves Schutz, Effect of orlistat in obese patients with binge eating disorder. Obesity Research. ,vol. 13, pp. 1701- 1708 ,(2005) , 10.1038/OBY.2005.208
Carolyn Cochrane, Robert Malcolm, Case report of abuse of Orlistat. Eating Behaviors. ,vol. 3, pp. 167- 169 ,(2002) , 10.1016/S1471-0153(01)00055-1
Angélica M. Claudino, Irismar R. de Oliveira, José Carlos Appolinario, Táki A. Cordás, Monica Duchesne, Rosely Sichieri, Josué Bacaltchuk, Double-Blind, Randomized, Placebo-Controlled Trial of Topiramate Plus Cognitive-Behavior Therapy in Binge-Eating Disorder The Journal of Clinical Psychiatry. ,vol. 68, pp. 1324- 1332 ,(2007) , 10.4088/JCP.V68N0901
H Ziauddeen, S R Chamberlain, P J Nathan, A Koch, K Maltby, M Bush, W X Tao, A Napolitano, A L Skeggs, A C Brooke, L Cheke, N S Clayton, I Sadaf Farooqi, S O'Rahilly, D Waterworth, K Song, L Hosking, D B Richards, P C Fletcher, E T Bullmore, Effects of the mu-opioid receptor antagonist GSK1521498 on hedonic and consummatory eating behaviour: a proof of mechanism study in binge-eating obese subjects Molecular Psychiatry. ,vol. 18, pp. 1287- 1293 ,(2013) , 10.1038/MP.2012.154
Anna I. Guerdjikova, Susan L. McElroy, Jeffrey A. Welge, Erik Nelson, Paul E. Keck, James I. Hudson, Lamotrigine in the treatment of binge-eating disorder with obesity: a randomized, placebo-controlled monotherapy trial. International Clinical Psychopharmacology. ,vol. 24, pp. 150- 158 ,(2009) , 10.1097/YIC.0B013E328329C7B5
Lori A. Schweickert, Michael Strober, Andrea Moskowitz, Efficacy of methylphenidate in bulimia nervosa comorbid with attention-deficit hyperactivity disorder: A case report International Journal of Eating Disorders. ,vol. 21, pp. 299- 301 ,(1997) , 10.1002/(SICI)1098-108X(199704)21:3<299::AID-EAT11>3.0.CO;2-W
Jeffrey M. Jonas, Mark S. Gold, The use of opiate antagonists in treating bulimia: A study of low-dose versus high-dose naltrexone Psychiatry Research-neuroimaging. ,vol. 24, pp. 195- 199 ,(1988) , 10.1016/0165-1781(88)90062-5
Joel Yager, Pauline S. Powers, Clinical Manual of Eating Disorders ,(2007)